No Data
No Data
No Data
Hong Kong Stock IPO News: Today Meng Jinyuan listed.
November 29th, Gelonghui: Today, Mengjinyuan (2585.HK) went public, Duodian Intelligence (2586.HK), and Reshaping Energy (2570.HK) are in the subscription period.
New stock preview: Duodian Intelligence (2586.HK)
The company provides digital retail solutions for local retailers. Local retail refers to businesses that sell commodities to nearby consumers through offline or online channels. The company mainly offers solutions in the mainland and has successfully expanded its business to Asia.
Multiple Points Smart Intelligence launches its IPO, introducing Jardine as a cornerstone investor, and will be listed in Hong Kong on December 6.
Multiple Points Smart Intelligence launches its IPO, introducing Jardine as a cornerstone investor, and will be listed in Hong Kong on December 6.
Dmall Launches Up to HK$779 Million Hong Kong IPO
【New Stock IPO】 UCommune (02586) is now open for subscription. Entry fee is 3,051.46 Hong Kong dollars.
Jinwu Financial News | Multi-Point Intelligence (02586) is starting its public offering today, intending to issue 25.774 million shares, of which 10% is for public sale in Hong Kong, and the remaining for international placement, with an additional 15% over-allotment option. The offer price per share will be 30.21 HKD, with a minimum purchase of 100 shares and an entry fee of 3,051.46 HKD. ubs group, China Merchants International, and china merchants are the joint sponsors. The shares are expected to be listed on December 6. The company anticipates that the net proceeds from fundraising will be approximately 0.624 billion HKD, with about 42.1% planned for developing new applications and service modules; 30% for.
Selected Announcement | Sino Biopharm's Class 1 innovative drug approved for new indications; LAKAI Pharmaceutical completes the placement of 17.636 million shares, raising approximately 0.23 billion Hong Kong dollars.
The innovative drug GLP-1R/GCGR dual agonist CMS-D005 from cms has received notification of clinical trial approval; Multiple Digital Intelligence is set to launch an IPO from November 28 to December 3, planning to globally issue 25.774 million shares.
No Data
No Data